covid-19July 6, 2020 Regeneron starts Phase 3 trial of Covid-19 antibody cocktail An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug’s ability to prevent and treat coronavirus infection. Related posts U.K.'s Johnson launches mass testing…Do you need a Covid-19…What's behind workers' hesitation to…Fully vaccinated people can travel…Younger Latino men are Covid's…Salmonella infections in eight states…Salmonella infections in eight states…The U.S. isn't losing to…Virus-killing robot tested for use…In Covid fight, Cuba touts…